Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
migraine
Pharma
Ipsen’s Botox rival Dysport posts dual ph. 3 wins in migraine
Dysport is now the first botulinum toxin to report positive phase 3 results in both episodic and chronic migraines, according to Ipsen.
Angus Liu
Jul 9, 2026 10:36am
Lundbeck hit with untitled letter over Vyepti efficacy claims
Jul 8, 2026 4:23pm
Teva's innovative drugs helped carry strong Q1
Apr 29, 2026 2:27pm
In Lilly patent spat, appeals court revives $177M verdict to Teva
Apr 17, 2026 10:16am
AbbVie has ‘Love in Mind’ with new migraine educational campaign
Feb 2, 2026 12:33pm
Lundbeck stays positive on Rexulti PTSD use despite adcomm vote
Aug 15, 2025 10:50am
